Chemokine receptor antagonists: overcoming developmental hurdles
- 12 December 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 8 (1), 23-33
- https://doi.org/10.1038/nrd2734
Abstract
Chemokine receptors have a key role in the pathogenesis of autoimmune diseases, inflammation and viral infection. However, with the exception of selective CCR5 antagonists for HIV, the promise of obtaining new therapeutics related to chemokine receptors has not yet been realized. This article highlights some of the recent failures in the clinical trials of chemokine receptor antagonists and explores possible reasons as to why this might have occurred. Such reasons include the lack of predictability of animal models and redundancy of the target. A potential solution could be to develop drugs that target more than one receptor--known as polypharmacology--which could be a novel way to generate effective therapeutics.Keywords
This publication has 111 references indexed in Scilit:
- Advances in Anti-Inflammatory TherapeuticsExpert Opinion on Investigational Drugs, 2007
- Phase I Evaluation of the Safety,??Pharmacokinetics and Pharmacodynamics of CP-481,715Clinical Pharmacokinetics, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivoBritish Journal of Pharmacology, 2006
- Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental ValidationPublished by Elsevier BV ,2006
- Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in respondersAnnals Of The Rheumatic Diseases, 2006
- Misbehaving macrophages in the pathogenesis of psoriasisJCI Insight, 2006
- Chemokine receptor expression in rat adjuvant‐induced arthritisArthritis & Rheumatism, 2005
- The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry InhibitorMolecular Pharmacology, 2005
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976